PRAX vs RAPP Stock Comparison
PRAX currently leads RAPP in this stock comparison, with AIQ scores of 57 vs 43. The clearest difference is quality.
What is the main difference between PRAX and RAPP?
PRAX leads the current stock comparison as Praxis Precision Medicines, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Praxis Precision Medicines, Inc. vs Rapport Therapeutics, Inc. Common Stock
PRAX leads
PRAX leads by 14 AIQ points, primarily on Quality and Momentum. Wall Street currently favors RAPP on target upside.
Competitive: 3 of 5 evidence groups support PRAX, and its current signal state is conflicted.
Praxis Precision Medicines, Inc.
Rapport Therapeutics, Inc. Common Stock
The Algovestiq AIQ Score currently favors PRAX over RAPP, 57 versus 43 as of Nov 15, 2026. PRAX's advantage is driven primarily by stronger quality and momentum. PRAX also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors RAPP. 3 of 5 covered evidence groups favor PRAX today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. PRAX lead: Stable — the AIQ differential has held near 14 points over 30 sessions.
Compare Praxis Precision Medicines, Inc. and Rapport Therapeutics, Inc. Common Stock across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare PRAX and RAPP against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality72 vs 57PRAX +15
- Momentum48 vs 33PRAX +15
- Risk Resilience47 vs 39PRAX +8
3 of 5 evidence groups favor PRAX. PRAX’s edge is concentrated in quality and momentum.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum +1
New signals
- Low Volume Rally Warning — bearish, volume, short horizon (0.72x)
Largest factor move: Value +1, not enough on its own to move the overall score.
New signals
- OBV Bullish Divergence — bullish, volume, medium horizon (-5.2%)
- RSI Bullish Divergence — bullish, momentum, medium horizon
PRAX's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — PRAX and RAPP both carry a full feed there.
The central trade-off
PRAX (Praxis Precision Medicines, Inc.): the stronger current systematic profile, led by quality and momentum.
RAPP (Rapport Therapeutics, Inc. Common Stock): the counter-case, on analyst expectations — but at materially higher volatility, 111.1% against 93.7%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
PRAXPRAX on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
RAPPRAPP on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
PRAXPRAX on the Momentum factor, by 15 points.
Lower downside
PRAXPRAX on Risk Resilience, by 8 points.
Analyst upside
RAPPRAPP on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors PRAX, analyst targets favor RAPP. That disagreement is the most useful thing on this page.
| Measure | PRAX | RAPP | Note |
|---|---|---|---|
| Implied upside to target | +101.2% | +173.9% | RAPP has more room |
| Target dispersion | +19.8% | +61.4% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 21 | 16 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 5 covered evidence groups favor PRAX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | PRAX | 57 vs 43 |
| Fundamentals | Even | revenue growth 0% vs 0%; EPS growth -12.5% vs 29.4%; TTM ROE -7.5% vs -10.3% |
| Valuation | Not covered | Not covered |
| Technicals | PRAX | Price vs 50-day 13.2% vs -18.1%; vs 200-day 4.3% vs -26.5% |
| Risk Resilience | PRAX | Risk Resilience 47 vs 39 |
| Analyst expectations | RAPP | Target upside 101.2% vs 173.9% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of PRAX and RAPP and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 14 points. (supports the conclusion holding)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PRAX.
How the comparison changed
120 daily snapshots · May 27 – Nov 13PRAX lead: Stable — the AIQ differential has held near 14 points over 30 sessions.
- Today
- PRAX +14
- 57 vs 43
- 7 sessions ago
- PRAX +16
- 58 vs 42
- 30 sessions ago
- PRAX +12
- 57 vs 45
- 90 sessions ago
- PRAX +4
- 69 vs 65
The lead changed hands 3 times in this window, most recently on Jul 29 when RAPP moved ahead of PRAX.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
3 bullish / 3 bearish / 2 neutral, conflicted
Only PRAX
- ADX Trend Strengthening — neutral, trend, medium horizon
- Beta Spike Warning — bearish, risk_regime, long horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Keltner Channel Breakout — bullish, volatility, short horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.72x)
- TRIX Bullish Signal — bullish, momentum, short horizon
2 bullish / 2 bearish / 1 neutral, conflicted
Only RAPP
- Downtrend Structure Active — bearish, trend, long horizon
- OBV Bullish Divergence — bullish, volume, medium horizon (-5.2%)
- RSI Bullish Divergence — bullish, momentum, medium horizon
Both carry 2 more signals that do not separate them: Death Cross Active, ATR Expansion - Breakout Mode.
PRAX leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +1.04%, AIQ +1 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.16%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1RAPP closes the Quality gap — currently 15 points behind, the largest single contributor to PRAX's edge.
- 2RAPP's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3PRAX's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | PRAX | RAPP |
|---|---|---|
| Revenue growth (YoY) | 0% | 0% |
| EPS growth (YoY) | -12.5% | 29.4% |
| Gross margin | 0% | 100% |
| Operating margin | 0% | -8.4% |
| Return on equity (TTM) | -7.5% | -10.3% |
| Debt to equity | 0 | 0.02 |
Performance
PRAX leads 6 of 6 windows| Metric | PRAX | RAPP |
|---|---|---|
| 1 week (5 sessions) | 18.2% | 7% |
| 1 month (20 sessions) | 35.7% | -5.2% |
| 3 months (63 sessions) | -12.8% | -46% |
| 6 months (126 sessions) | -4.2% | -29.5% |
| Year to date | 11.3% | -13.8% |
| 1 year (252 sessions) | 78.7% | 3.9% |
Technicals
PRAX has the stronger structure| Metric | PRAX | RAPP |
|---|---|---|
| RSI (14) | 61.4 | 44.9 |
| ADX (14) | 23.4 | 31.4 |
| Price vs 50-day | 13.2% | -18.1% |
| Price vs 200-day | 4.3% | -26.5% |
| Volatility (1M, annualized) | 93.7% | 111.1% |
Risk
PRAX is the more resilient| Metric | PRAX | RAPP |
|---|---|---|
| Beta | 1.58 | 1.27 |
| Sharpe ratio | 1.13 | 0.35 |
| Sortino ratio | 1.93 | 0.47 |
| Max drawdown | -38.1% | -57.1% |
| Current drawdown | -15.1% | -50.2% |
| Annualized volatility | 75.1% | 62.3% |
| Value at risk (95%) | -5.5% | -5.8% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, PRAX or RAPP?
On the Algovestiq AIQ Score, PRAX is the stronger of the two as of Nov 15, 2026, scoring 57 against RAPP's 43. The edge comes from quality and momentum. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is PRAX or RAPP the better buy right now?
PRAX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor PRAX over RAPP?
The composite weights Quality, Value, Momentum and Risk Resilience. PRAX leads Quality by 15 points; PRAX leads Momentum by 15 points; PRAX leads Risk Resilience by 8 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, PRAX or RAPP?
Analyst price targets imply +101.2% upside for PRAX and +173.9% for RAPP, so the Street currently favors RAPP. That points the opposite way to the AIQ Score, which favors PRAX. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, PRAX or RAPP?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, PRAX or RAPP?
RAPP on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, PRAX or RAPP?
PRAX on the Momentum factor, by 15 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, PRAX or RAPP?
PRAX is the more resilient of the two, so the other name carries the higher downside risk. PRAX on Risk Resilience, by 8 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is PRAX more profitable than RAPP?
PRAX leads on the comparable margin measures — gross margin 0% vs 100%; operating margin 0% vs -8.4%; ttm roe -7.5% vs -10.3%.
Is PRAX's lead over RAPP getting stronger or weaker?
PRAX lead: Stable — the AIQ differential has held near 14 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 3 times in that window, most recently on 2026-07-29, when RAPP moved ahead of PRAX.
What would change the PRAX vs RAPP verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: RAPP closes the Quality gap — currently 15 points behind, the largest single contributor to PRAX's edge; RAPP's Death Cross Active resolves — a bearish trend rule currently active against it; PRAX's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about PRAX and RAPP?
PRAX: 3 bullish / 3 bearish / 2 neutral, conflicted. RAPP: 2 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on PRAX is Death Cross Active (bearish, long horizon). On RAPP it is Death Cross Active (bearish, long horizon).
Compare PRAX and RAPP with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.